UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005436
Receipt number R000006451
Scientific Title Evaluation of 62Cu-ATSM PET/CT in carbon ion  radiotherapy to refractory cancer
Date of disclosure of the study information 2011/04/13
Last modified on 2012/12/26 08:40:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of 62Cu-ATSM PET/CT in carbon ion  radiotherapy to refractory cancer

Acronym

ATSM clinical study for refractory cancer 1

Scientific Title

Evaluation of 62Cu-ATSM PET/CT in carbon ion  radiotherapy to refractory cancer

Scientific Title:Acronym

ATSM clinical study for refractory cancer 1

Region

Japan


Condition

Condition

Lung cancer, Head and neck cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the correlation between the accumulation of the hypoxia probe 62Cu-ATSM and the outcome of carbon ion radiotherapy or the intractable region in refractory cancer, through 62Cu-ATSM hypoxia PET/CT imaging in cancer patients planned for carbon ion radiotherapy at NIRS.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Qualitative and semi-quantitative assessment of tumor uptake on 62Cu-ATSM and FDG PET images.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine Maneuver

Interventions/Control_1

62Cu-ATSM and 18FDG PET imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Lung cancer and head and neck cancer patients planned for carbon ion radiotherapy at NIRS

Key exclusion criteria

Patients regarded as unsuitable by principle investigators

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsuneo Saga

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1 Anagawa Inage, Chiba

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1 Anagawa Inage, Chiba

TEL


Homepage URL


Email



Sponsor or person

Institute

National Institute of Radiological Sciences

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 02 Month 28 Day

Date of IRB


Anticipated trial start date

2011 Year 05 Month 30 Day

Last follow-up date

2011 Year 06 Month 28 Day

Date of closure to data entry

2012 Year 04 Month 05 Day

Date trial data considered complete

2012 Year 04 Month 05 Day

Date analysis concluded

2012 Year 04 Month 05 Day


Other

Other related information



Management information

Registered date

2011 Year 04 Month 13 Day

Last modified on

2012 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006451


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name